INIS
apolipoproteins
88%
transcription
88%
receptors
59%
humans
58%
fatty acids
56%
proteins
51%
inflammation
41%
chains
41%
messenger-rna
40%
production
40%
secretion
35%
inhibition
32%
liver
29%
genes
23%
phosphorylation
23%
concentration
22%
insulin
21%
liver cells
20%
peptides
19%
endoplasmic reticulum
19%
dna damages
19%
apoptosis
19%
amino acids
19%
increasing
17%
kinases
16%
lipoproteins
15%
density
13%
doses
12%
hepatocytes
11%
phosphatases
11%
Keyphrases
Apolipoprotein A-I (ApoA-I)
100%
Peroxisome Proliferator-activated Receptor
62%
HepG2 Cells
53%
Transactivation
40%
Inflammation
34%
Short-chain Fatty Acids
29%
Endoplasmic Reticulum Stress (ER stress)
29%
Metabolic Syndrome
23%
Amino Acids
19%
MRNA Expression
17%
CCAAT/enhancer-binding Protein Homologous Protein
16%
PPARalpha
14%
Phosphorylation
14%
Amoxicillin
13%
Nuclear factor-κB
13%
Alpha Activation
13%
Activating Transcription Factor 3 (ATF3)
12%
Caco-2 Cells
12%
Insulin Resistance
12%
Induced Apoptosis
12%
Natural Compounds
12%
Activator protein-1 (AP-1)
12%
Metabolic Disturbances
12%
Transcriptional Activation
12%
MKP-1
11%
Adipocyte
11%
C-Jun
11%
Phosphatase
11%
Obesity
11%
NF-B
10%
Biochemistry, Genetics and Molecular Biology
Apolipoprotein
39%
Transcription
31%
Endoplasmic Reticulum Stress
29%
Peroxisome Proliferator-Activated Receptor Alpha
19%
CCAAT Enhancer Binding Protein Beta
19%
Insulin Resistance
11%
Short-Chain Fatty Acid
11%
Adipocyte
11%
Phosphatase
11%
ATF3
11%
N-Terminus
9%
Epidermal Growth Factor
9%
HLA-E
9%
Natural Killer Cell
9%
DNA Damage Response
9%
Glutamine
9%
Leucine
9%
Cell Function
9%
Pancreatic Lipase
9%
DNA Damage
9%
Triacylglycerol Lipase
9%
Cancer Cell
9%
Amino Acids
9%
Butyric Acid
9%
Interleukin 8
9%
Phosphotransferase
9%
Kinase
9%
Cell Invasion
9%
Alpha-Adrenergic Agonist
9%
Mitochondrial Disorder
9%
